Systematic Review and Meta-Analysis of the Impact of Intra-Operative Ultrasound Guidance Breast-Conserving Surgery in Early Breast Cancer

Review Article

Austin J Surg. 2021; 8(2): 1267.

Systematic Review and Meta-Analysis of the Impact of Intra-Operative Ultrasound Guidance Breast-Conserving Surgery in Early Breast Cancer

Tin SMM1, Kurup V2, Cheema I1, Viswanath YKS3* and Razdan S3

¹Department of Surgery, South Tees University Hospitals NHS Foundation Trust, United Kingdom

²Department of Surgery, North Tees University Hospitals NHS Foundation trust, United Kingdom

³Department of Surgery, James Cook University Hospital, South Tees University Hospitals NHS Foundation Trust, United Kingdom

*Corresponding author: Viswanath YKS, Department of Surgery, James Cook University Hospital, South Tees University Hospitals NHS Foundation Trust, Middlesbrough, TS22 5QE, United Kingdom

Received: March 17, 2021; Accepted: April 03, 2021; Published: April 10, 2021

Abstract

Systematic review and meta-analysis of the impact of intra-operative ultrasound guided breast-conserving surgery in early breast cancer.

Background: Breast Conservation (BCS) is the standard surgical procedure for early breast cancer. It is challenging for surgeons to achieve adequate excision of the lesion with clear margins and acceptable cosmesis. A continuous Intra-Operative Ultrasound (IOUS) is used during BCS in volume precision surgery. We reviewed its effectiveness to obtain clear margins, low excision volume and better cosmetic outcome during BCS.

Methods: We searched three bibliographic databases (MEDLINE, CINAHL, Cochrane Library online) for relevant published and unpublished literature from their inception until December 2019. The randomized controlled trials of the impact of IOUS on excision volume, margin status and cosmetic outcome was assessed, and meta-analysis carried out for margin status with narrative summary was done for other results.

Results: This study included four articles in the systematic review. A total of 207 patients with IOUS and 192 patients with Palpation Guided (PGS) BCS was studied in this review. The standardised mean difference of excision volume for 2 trials was -0.31 (-0.62, -0.00) and -0.50 (-0.85, -0.16) with p-value of 0.048 and 0.004. There was no significant volume difference in the remaining two studies. The positive margin rate reduced significantly with IOUS guidance with the pooled OR was 0.19 (95% CI: 0.09, 0.41) with no heterogeneity among studies (p=0.72, I2= 0%). The overall cosmetic outcome favoured satisfaction in both ultrasound-guided and palpation guided BCS groups without significant difference.

Conclusion: This study suggests that the use of IOUS provides a statistically significant, less positive margin without a considerable difference in excisional volume. Overall, satisfaction exceeds dissatisfaction with ultrasound-guided Breast-conserving surgery. However, there is insufficient evidence to support the better cosmetic outcome in the IOUS group.

Keywords: Breast cancer; Breast-conserving surgery; Image guidance; Satisfaction; Ultrasound

Abbreviations

BCS: Breast Conserving Surgery; IOUS: Intra-Operative Ultrasound

Introduction

Breast cancer is the most common cancer in the UK, with approximately 54,000 new cases diagnosed each year [1]. Overall, survival has improved steadily over time due to increasing awareness, early diagnosis, advances in adjuvant treatment and widespread use of the NHS breast screening program. Early-stage (79-87 % at Stage 1-2) breast cancer patients are diagnosed than a late stage (13-21% at stage 3 or 4) [1].

Breast-Conserving Therapy (BCT) is an established standard of care for women with early breast cancer. The patient’s overall survival with BCT is comparable to those treated with mastectomy [2]. This study concluded as BCS had an improved overall survival rate compared to mastectomy in N0-N1 tumour but no significant difference in N2-3 patients. Overall survival was better with BCT (HR=1.42, 95% CI 1.16-1.74) in the young age group. The large retrospective cohort study of 5335 patients reported 3, 5, and 10- year overall survival was 96.5% vs 93.4%, 92.9% vs 88.3% and 80.9% vs 67.2%, respectively [3]. The meta-analysis of Breast-conserving surgery and mastectomy for locally advanced breast cancer reported no significant difference in local and regional recurrence rate (OR=0.83, 0.60, 1.15, p=0.26) and higher disease-free survival rate (OR=2.35, 1.84, 3.01, p=<0.01) in Breast-conserving surgery [4].

Breast-Conserving Surgery (BCS) aims to complete tumour excision with clear margins while maintaining a reasonable cosmetic outcome [5]. To fulfil this principle, various techniques have been used to localize the tumour, such as wire localization, seed localization, MarginProbe, ultrasound and specimen X ray, intra-operative MRI margin, and margin assessment 3D specimen evaluation, Clear-Edge imaging and I Knife. The wire or seed localization and specimen X-ray is the gold standard for nonpalpable breast cancer. For palpable breast cancer, surgeons typically rely on pre-operative imaging and their skills and experience. This technique may be insufficient in differentiating tumour from surrounding tissue, especially in highly glandular breasts. It can lead to a high involved margin rate. Reexcision of the positive margin will affect the patient’s emotional status, increase wound infection rate, delay adjuvant treatment, and increase scar formation [6,7].

Consequently, it may necessitate further cosmetic procedure and incur supplementary healthcare cost. Use of Intra-operative ultrasound aids to estimate the size of the tumour more accurately and improve the negative margin rate with a better cosmetic outcome [8,9]. It is a cost-effective technology compared to re-excision and other real-time imaging.

The rate of the negative margin of breast cancer was significantly higher with the IOUS group than PGS (OR= 2.75, 95% CI: 1.66-4.55, p= 0.193) for both palpable and nonpalpable breast cancer [10]. The localisation accuracy was 100%, and the negative margin rate was 91.01% with continuous intra-operative ultrasound monitoring by the surgeon [9]. The relative risk for re-excision in the ultrasound group due to positive margin was 0.82 (95% CI: 0.23, 2.93), and clear margins were achieved in 88% (IOUS) and 86% (PGS) (p=0.91) for both palpable and nonpalpable breast cancer [11]. Houssami and colleagues performed a study-level meta-analysis that included 33 eligible studies and over 28,000 women with early-stage breast cancer. A positive margin was associated with increased Local Recurrence (LR) (OR= 2.44; 95% CI 1.97-3.03; p<0.001), even after adjusting for the use of a radiation boost or adjuvant endocrine therapy [12]. Notably, there was no evidence of a decreased LR risk with increasing negative margin widths from 1mm to 2mm to 5mm (p=0.90). Analysis of 10-years data from the Breast cancer quality assurance project showed an involved margin or margin of 1mm increased risk of Locoregional Recurrence (LRR) (HR 3.24,95% CI 1.46-7.17, p=0.004) whilst margin 2mm or greater had no effect on LRR [13]. These data confirm that even with modern multimodality treatment, a negative margin reduces the risk of LR; however, increasing the size of a negative margin is not significantly associated with improvement in local control.

The cosmetic outcome depends on the volume of tissue excision and secondary treatment with radiotherapy. Poor cosmetic outcome was observed in up to 30% of patients after BCS [14]. In an extensive survey among 963 women treated with BCS for breast cancer, cosmetic results were scored as 3.4 on a 5-point scale with from 1 (very dissatisfied) to 5 (very satisfied) [15]. COBALT trial reported IOUS resulted in improvement of cosmetic outcomes within one year follow up point. Poor cosmetic outcome rated at the end of follow up was 11% for USS and 21% for PGS [9,16].

This study will investigate the margin involvement, excision volume of breast tissue and cosmetic outcome and patient satisfaction in a breast cancer patient who were treated with Intra-operative ultrasound guided Breast conserving surgery.

Methods

Search strategy

After the scoping searches, three bibliographic databases (MEDLINE, CINAHL, Cochrane Library online) were searched for relevant published and unpublished literature from their inception until December 2019. In order to reduce the bias, we tabulated searches without search filters or procedure specific keywords that would limit results to specific study design or diagnostic groups [17]. To fulfil the criteria for structured literature search, Boolean logic was used. In addition to searching bibliographic databases, hand searching, and citation chaining were performed. This search was performed independently by 2 reviewers to increase the validity of the results. Duplicating the study selection process reduces both the risk of making mistakes and the possibility that selection is influenced by a single person’s biases [18]. Region was not limited but language was limited (English). This study emphasized effect of ultrasound guided BCS on excision volume, margin status and cosmetic outcome compared with conventional palpation guided BCS.

Inclusion and Exclusion criteria

Two reviewers independently screened all the titles and abstracts. The full-text papers of relevant abstract were obtained and assessed according to inclusion criteria. The inclusion criteria were as follow: the patients with early palpable breast cancer (T1-T2, N0-N1), who were treated with Intra-Operative Ultrasound Guided BCS (IOUS) or Palpation Guided BCS (PGS) to evaluate the excisional volume, margin status and cosmetic outcome. The randomized controlled trials were included in the study.

This review excluded the papers which assessed the nonpalpable breast cancer or locally advanced breast cancer, other image- guided localization techniques and procedures other than BCS. The studies investigating cavity shaving or oncoplastic breast surgery were also excluded.

Quality assessment and data extraction

Each paper’s quality was assessed with quality assessment tools for randomized controlled trial. The Revised Cochrane risk-of-bias tool for randomized trials (RoB 2) and Centre for Research Dissemination (CRD) check list were used for individual paper. The information was careful extracted from individual studies independently. Thereafter, the data extraction was redone at different time and both datasets were cross-checked to ensure accuracy and completeness. The following variables were extracted from each study: first named author, year of publication, study design, type of breast cancer, number of cases and control, number of patients with positive margins, specimen volume and cosmetic outcomes and sponsorship.

Statistical analysis

After extracting the relevant data according to study inclusion criteria, the Cochrane Collaboration review Manager (Rev Man 5) statistical software were used for data analysis. Continuous data (Excision volume) was presented separately with mean, standard deviation, mean difference and p value to interpret the final outcome. The Standardized mean difference was used to assess the excised volume between two groups. It estimates the amount by which the experimental intervention (IOUS) changes the outcome on average compared with the control (PGS).

For margin positivity, the Odd Ratio (OR) and Risk difference with its variance and 95% Confidence Interval (CI) were estimated to assess the association between two techniques. The heterogenicity was evaluated by I2 test. I2 value was 0% for positive margin, which represents no heterogeneity among these studies. Therefore, fixedeffect model (The Mantel-Haenszed Method) was used to calculate the pooled OR. Forest plots were used to present the outcomes of meta-analysis. Publication bias was investigated by Funnel plot.

The cosmetic outcome (patient satisfaction) was estimated with OR of having a worse cosmetic outcome based on the propotional odds model for ordinal responses. The patient and assessor satisfaction were presented with percentage.

Results

After scope electronic and hand search, 84 citations were identified. Their titles were assessed for the relevance to the review and duplication were removed, resulting in 24 potential citations being retained. The abstracts were reviewed for these studies and 7 were selected for full article reviews according to inclusion and exclusion criteria of the study. One article was rejected after full text review because of study protocol. Two relevant poster presentations of RCT were identified and requested to authors for full text paper. These two papers were not accessible. Hence, these poster presentations with insufficient information were rejected from the review. Therefore, 4 articles were included in the systematic review. Identification of included studies is shown (Figure 1). Overall, 207 patients in IOUS and 192 patients in PGS were included in the study.